Differential cytokine patterns in mouse macrophages and gingival fibroblasts after stimulation with porphyromonas gingivalis or escherichia coli lipopolysaccharide

Journal of Periodontology

Volumn 81, Issue 12, 2010, Pages 1850-1857

  Jones, Katy J ^a   Ekhlassi, Sanaz ^a   Montufar Solis, Dina ^a   Klein, John R ^a   Schaefer, Jeremy S ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Bacterial polysaccharides; Chemokines; Cytokines; Fibroblast

Indexed keywords

CCCL4 PROTEIN, MOUSE; CCL2 PROTEIN, MOUSE; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; NOS2 PROTEIN, MOUSE;

ANIMAL; ARTICLE; C57BL MOUSE; CELL LINE; COMPARATIVE STUDY; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; FIBROBLAST; GINGIVA; IMMUNOLOGY; LUNG ALVEOLUS MACROPHAGE; MICROBIOLOGY; MOUSE; MOUSE STRAIN; PORPHYROMONAS GINGIVALIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL LINE, TRANSFORMED; CHEMOKINE CCL2; CHEMOKINE CCL3; CHEMOKINE CCL4; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; FIBROBLASTS; GINGIVA; INTERLEUKIN-1BETA; INTERLEUKIN-23; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; NITRIC OXIDE SYNTHASE TYPE II; PORPHYROMONAS GINGIVALIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 78650127375     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2010.100226     Document Type: Article

References (32)

1. Armitage GC. Periodontal diagnoses and classification of periodontal diseases. Periodontol 2000 2004;34:9-21.
2. Page RC, Schroeder HE. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest 1976;34:235-249.
3. Kornman KS. Mapping the pathogenesis of periodontitis: A new look. J Periodontol 2008;79(Suppl.8):1560-1568.
4. Griffen AL, Becker MR, Lyons SR, Moeschberger ML, Leys EJ. Prevalence of Porphyromonas gingivalis and periodontal health status. J Clin Microbiol 1998;36:3239-3242.
5. Melvin WL, Assad DA, Miller GA, Gher ME, Simonson L, York AK. Comparison of DNA probe and ELISA microbial analysis methods and their association with adult periodontitis. J Periodontol 1994;65:576-582.
6. Socransky SS, Haffajee AD, Smith C, Dibart S. Relation of counts of microbial species to clinical status at the sampled site. J Clin Periodontol 1991;18:766-775.
7. Holt SC, Ebersole J, Felton J, Brunsvold M, Kornman KS. Implantation of Bacteroides gingivalis in nonhuman primates initiates progression of periodontitis. Science 1988;239:55-57.
8. Ali RW, Lie T, Skaug N. Early effects of periodontal therapy on the detection frequency of four putative periodontal pathogens in adults. J Periodontol 1992;63:540-547.
9. Haffajee AD, Dzink JL, Socransky SS. Effect of modified Widman flap surgery and systemic tetracycline on the subgingival microbiota of periodontal lesions. J Clin Periodontol 1988;15:255-262.
10. Haffajee AD, Socransky SS. Microbial etiological agents of destructive periodontal diseases. Periodontol 2000 1994;5:78-111.
11. Hassell TM. Tissues and cells of the periodontium. Periodontol 2000 1993;3:9-38.
12. Ekhlassi S, Scruggs LY, Garza T, Montufar-Solis D, Moretti AJ, Klein JR. Porphyromonas gingivalis lipopolysaccharide induces tumor necrosis factor-α and interleukin-6 secretion, and CCL25 gene expression, in mouse primary gingival cell lines: Interleukin-6-driven activation of CCL2. J Periodontal Res 2008;43:431-439.
13. -△△C(T)) method. Methods 2001;25:402-408.
14. Setoguchi M, Nasu N, Yoshida S, Higuchi Y, Akizuki S, Yamamoto S. Mouse and human CD14 (myeloid cellspecific leucine-rich glycoprotein) primary structure deduced from cDNA clones. Biochim Biophys Acta 1989;1008:213-222.
15. Sugawara S, Sugiyama A, Nemoto E, Rikiishi H, Takada H. Heterogeneous expression and release of CD14 by human gingival fibroblasts: Characterization and CD14-mediated interleukin-8 secretion in response to lipopolysaccharide. Infect Immun 1998;66:3043-3049.
16. Zhou Q, Desta T, Fenton M, Graves DT, Amar S. Cytokine profiling of macrophages exposed to Porphyromonas gingivalis, its lipopolysaccharide, or its FimA protein. Infect Immun 2005;73:935-943.
17. Hamedi M, Belibasakis GN, Cruchley AT, Rangarajan M, Curtis MA, Bostanci N. Porphyromonas gingivalis culture supernatants differentially regulate interleukin-1beta and interleukin-18 in human monocytic cells. Cytokine 2009;45:99-104.
18. Hirschfeld M, Weis JJ, Toshchakov V, et al. Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun 2001;69:1477-1482.
19. Wang PL, Ohura K. Porphyromonas gingivalis lipopolysaccharide signaling in gingival fibroblasts-CD14 and Toll-like receptors. Crit Rev Oral Biol Med 2002;13:132-142.
20. Cunningham MD, Bajorath J, Somerville JE, Darveau RP. Escherichia coli and Porphyromonas gingivalis lipopolysaccharide interactions with CD14: Implications for myeloid and nonmyeloid cell activation. Clin Infect Dis 1999;28:497-504.
21. Cunningham MD, Seachord C, Ratcliffe K, Bainbridge B, Aruffo A, Darveau RP. Helicobacter pylori and Porphyromonas gingivalis lipopolysaccharides are poorly transferred to recombinant soluble CD14. Infect Immun 1996;64:3601-3608.
22. Cunningham MD, Shapiro RA, Seachord C, Ratcliffe K, Cassiano L, Darveau RP. CD14 employs hydrophilic regions to "capture" lipopolysaccharides. J Immunol 2000;164:3255-3263.
23. Shapiro RA, Cunningham MD, Ratcliffe K, et al. Identification of CD14 residues involved in specific lipopolysaccharide recognition. Infect Immun 1997;65:293-297.
24. Takeuchi O, Hoshino K, Kawai T, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999;11:443-451.
25. Beutler B. Toll-like receptors: How they work and what they do. Curr Opin Hematol 2002;9:2-10.
26. Watanabe A, Takeshita A, Kitano S, Hanazawa S. CD14-mediated signal pathway of Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts. Infect Immun 1996;64:4488-4494.
27. Hajishengallis G, Tapping RI, Harokopakis E, et al. Differential interactions of fimbriae and lipopolysaccharide from Porphyromonas gingivalis with the Tolllike receptor 2-centred pattern recognition apparatus. Cell Microbiol 2006;8:1557-1570.
28. Kocgozlu L, Elkaim R, Tenenbaum H, Werner S. Variable cell responses to P. gingivalis lipopolysaccharide. J Dent Res 2009;88:741-745.
29. Wang PL, Sato K, Oido M, et al. Involvement of CD14 on human gingival fibroblasts in Porphyromonas gingivalis lipopolysaccharide-mediated interleukin-6 secretion. Arch Oral Biol 1998;43:687-694.
30. Kitchens RL, Wang P, Munford RS. Bacterial lipopolysaccharide can enter monocytes via two CD14-dependent pathways. J Immunol 1998;161:5534-5545.
31. Wang PL, Azuma Y, Shinohara M, Ohura K. Toll-like receptor 4-mediated signal pathway induced by Porphyromonas gingivalis lipopolysaccharide in human gingival fibroblasts. Biochem Biophys Res Commun 2000;273:1161-1167.
32. Reife RA, Shapiro RA, Bamber BA, Berry KK, Mick GE, Darveau RP. Porphyromonas gingivalis lipopolysaccharide is poorly recognized by molecular components of innate host defense in a mouse model of early inflammation. Infect Immun 1995;63:4686-4694.